Point72 Asset Management
INFI

Point72 Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Point72 Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-500,000
Closed -$6.71M – 818
2014
Q3 		$6.71M Buy
+500,000
New +$5.95M 0.05% 348

Other funds holding INFI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Point72 Asset Management's INFI Position: Q1 2022 in Review

Point72 Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2022, closing a stake of 770,552 shares — an estimated $1.73M sold.

Point72 Asset Management first reported a position in INFI in Q2 2014 and held it in 4 quarters. The position peaked at $43.5M in Q2 2014. 93 funds tracked by Wall St. Rank hold INFI as of Q1 2022.

  • Point72 Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Point72 Asset Management sold 770,552 Infinity Pharmaceuticals, Inc. shares in Q1 2022, an estimated $1.73M.
  • Point72 Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2014 and held it in 4 quarters.
  • Point72 Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $43.5M in Q2 2014.
  • 93 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2022.

Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.